These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mucus adhesion vs. mucus penetration? Screening nanomaterials for nasal inhalation by MD simulation. Gao X; Xiong Y; Chen H; Gao X; Dai J; Zhang Y; Zou W; Gao Y; Jiang Z; Han B J Control Release; 2023 Jan; 353():366-379. PubMed ID: 36462640 [TBL] [Abstract][Full Text] [Related]
3. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement. Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038 [TBL] [Abstract][Full Text] [Related]
4. Food-grade TiO Talbot P; Radziwill-Bienkowska JM; Kamphuis JBJ; Steenkeste K; Bettini S; Robert V; Noordine ML; Mayeur C; Gaultier E; Langella P; Robbe-Masselot C; Houdeau E; Thomas M; Mercier-Bonin M J Nanobiotechnology; 2018 Jun; 16(1):53. PubMed ID: 29921300 [TBL] [Abstract][Full Text] [Related]
5. Mucin Thin Layers: A Model for Mucus-Covered Tissues. Rondelli V; Cola ED; Koutsioubas A; Alongi J; Ferruti P; Ranucci E; Brocca P Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362433 [TBL] [Abstract][Full Text] [Related]
6. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering. Griffiths PC; Cattoz B; Ibrahim MS; Anuonye JC Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):218-22. PubMed ID: 25986588 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications. Hansen IM; Ebbesen MF; Kaspersen L; Thomsen T; Bienk K; Cai Y; Malle BM; Howard KA Mol Pharm; 2017 Jul; 14(7):2359-2367. PubMed ID: 28499338 [TBL] [Abstract][Full Text] [Related]
8. Exploring Mechanisms of Lipid Nanoparticle-Mucus Interactions in Healthy and Cystic Fibrosis Conditions. Tafech B; Rokhforouz MR; Leung J; Sung MM; Lin PJ; Sin DD; Lauster D; Block S; Quon BS; Tam Y; Cullis P; Feng JJ; Hedtrich S Adv Healthc Mater; 2024 Jul; 13(18):e2304525. PubMed ID: 38563726 [TBL] [Abstract][Full Text] [Related]
9. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it? Pearson JP; Chater PI; Wilcox MD Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320 [TBL] [Abstract][Full Text] [Related]
12. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Boegh M; Nielsen HM Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):179-86. PubMed ID: 25349046 [TBL] [Abstract][Full Text] [Related]
13. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models. Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Leal J; Smyth HDC; Ghosh D Int J Pharm; 2017 Oct; 532(1):555-572. PubMed ID: 28917986 [TBL] [Abstract][Full Text] [Related]
15. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery. Amin MK; Boateng JS Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455 [No Abstract] [Full Text] [Related]
16. Undefined role of mucus as a barrier in ocular drug delivery. Ruponen M; Urtti A Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770 [TBL] [Abstract][Full Text] [Related]
17. Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles. Li C; Liu Z; Yan X; Lu W; Liu Y Int J Pharm; 2015 Feb; 479(1):261-4. PubMed ID: 25528296 [TBL] [Abstract][Full Text] [Related]
18. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus. Lafitte G; Thuresson K; Jarwoll P; Nydén M Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]